Literature DB >> 31251980

Anesthetics disrupt growth cone guidance cue sensing through actions on the GABAA α2 receptor mediated by the immature chloride gradient.

Jing Xu1, Michael Xu2, YuChia Wang2, R Paige Mathena2, Jieqiong Wen1, Pengbo Zhang3, Orion Furmanski2, C David Mintz4.   

Abstract

BACKGROUND: General anesthetics (GAs) may exert harmful effects on the developing brain by disrupting neuronal circuit formation. Anesthetics that act on γ-aminobutyric acid (GABA) receptors can interfere with axonal growth cone guidance, a critical process in the assembly of neuronal circuitry. Here we investigate the mechanism by which isoflurane prevents sensing of the repulsive guidance cue, Semaphorin 3A (Sema3A).
METHODS: Growth cone sensing was assayed by measuring growth cone collapse in dissociated neocortical cultures exposed to recombinant Sema3A in the presence or absence of isoflurane and/or a panel of reagents with specific actions on components of the GABA receptor and chloride ion systems.
RESULTS: Isoflurane exposure prevents Sema3A induced growth cone collapse. A GABAA α2 specific agonist replicates this effect (36.83 ± 3.417% vs 70.82 ± 2.941%, in the Sema3A induced control group, p < 0.0001), but an α1-specific agonist does not. Both a Na-K-Cl cotransporter 1 antagonism (bumetanide, BUM) and a chloride ionophore (IONO) prevent isoflurane from disrupting growth cone sensing of Sema3A. (65.67 ± 3.775% in Iso + BUM group vs 67.45 ± 3.624% in Sema3A induced control group, 65.34 ± 1.678% in Iso + IONO group vs 68.71 ± 2.071% in Sema3A induced control group, no significant difference) (n = 96 growth cones per group).
CONCLUSION: Our data suggest that the effects of isoflurane on growth cone sensing are mediated by the α2 subunit of the GABAA receptor and also that they are dependent on the developmental chloride gradient, in which Cl- exhibits a depolarizing effect. These findings provide a rationale for why immature neurons are particularly susceptible to anesthetic toxicity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anesthesia; Chloride gradient; GABA(A)Rs; Growth cone; Neurotoxicity

Mesh:

Substances:

Year:  2019        PMID: 31251980      PMCID: PMC6650745          DOI: 10.1016/j.ntt.2019.106812

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  56 in total

1.  Turning of nerve growth cones induced by localized increases in intracellular calcium ions.

Authors:  J Q Zheng
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

2.  Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood.

Authors:  Lena S Sun; Guohua Li; Tonya L K Miller; Cynthia Salorio; Mary W Byrne; David C Bellinger; Caleb Ing; Raymond Park; Jerilynn Radcliffe; Stephen R Hays; Charles J DiMaggio; Timothy J Cooper; Virginia Rauh; Lynne G Maxwell; Ahrim Youn; Francis X McGowan
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

3.  Significance of GABA(A) receptor heterogeneity: clues from developing neurons.

Authors:  Jean-Marc Fritschy
Journal:  Adv Pharmacol       Date:  2015-01-14

4.  Cognitive and behavioral outcomes after early exposure to anesthesia and surgery.

Authors:  Randall P Flick; Slavica K Katusic; Robert C Colligan; Robert T Wilder; Robert G Voigt; Michael D Olson; Juraj Sprung; Amy L Weaver; Darrell R Schroeder; David O Warner
Journal:  Pediatrics       Date:  2011-10-03       Impact factor: 7.124

5.  Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial.

Authors:  Mary Ellen McCann; Jurgen C de Graaff; Liam Dorris; Nicola Disma; Davinia Withington; Graham Bell; Anneke Grobler; Robyn Stargatt; Rodney W Hunt; Suzette J Sheppard; Jacki Marmor; Gaia Giribaldi; David C Bellinger; Penelope L Hartmann; Pollyanna Hardy; Geoff Frawley; Francesca Izzo; Britta S von Ungern Sternberg; Anne Lynn; Niall Wilton; Martin Mueller; David M Polaner; Anthony R Absalom; Peter Szmuk; Neil Morton; Charles Berde; Sulpicio Soriano; Andrew J Davidson
Journal:  Lancet       Date:  2019-02-14       Impact factor: 79.321

6.  Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.

Authors:  Vesna Jevtovic-Todorovic; Richard E Hartman; Yukitoshi Izumi; Nicholas D Benshoff; Krikor Dikranian; Charles F Zorumski; John W Olney; David F Wozniak
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

Review 7.  Defining the role of GABA in cortical development.

Authors:  Doris D Wang; Arnold R Kriegstein
Journal:  J Physiol       Date:  2009-01-19       Impact factor: 5.182

Review 8.  The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.

Authors:  Kristopher T Kahle; Kevin J Staley
Journal:  Neurosurg Focus       Date:  2008-09       Impact factor: 4.047

9.  Early postnatal exposure to isoflurane causes cognitive deficits and disrupts development of newborn hippocampal neurons via activation of the mTOR pathway.

Authors:  Eunchai Kang; Danye Jiang; Yun Kyoung Ryu; Sanghee Lim; Minhye Kwak; Christy D Gray; Michael Xu; Jun H Choi; Sue Junn; Jieun Kim; Jing Xu; Michele Schaefer; Roger A Johns; Hongjun Song; Guo-Li Ming; C David Mintz
Journal:  PLoS Biol       Date:  2017-07-06       Impact factor: 8.029

Review 10.  Development and regulation of chloride homeostasis in the central nervous system.

Authors:  Miho Watanabe; Atsuo Fukuda
Journal:  Front Cell Neurosci       Date:  2015-09-24       Impact factor: 5.505

View more
  1 in total

1.  SEMA6D, Negatively Regulated by miR-7, Contributes to C28/I2 chondrocyte's Catabolic and Anabolic Activities via p38 Signaling Pathway.

Authors:  Haoyu Yang; Zhicheng Yang; Zhentang Yu; Chenwei Xiong; Yi Zhang; Junjie Zhang; Yong Huang; Xindie Zhou; Jin Li; Nanwei Xu
Journal:  Oxid Med Cell Longev       Date:  2022-06-16       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.